NIFTYMIDSMALLHEALTHCARE · NSE

Nifty MidSmall Healthcare

Index · View only — not on the trading terminal

₹52,624.9

+1.17% (+₹607.35)

Prev. close

₹52,017.55

Volume

3,23,00,519

As of

18 Sept 2026

Price history

₹52,624.9+₹4,380.05 (+9.08%) · 3M
12 Jun 202618 Sept 2026
₹52,743.95₹47,564.512 Jun07 Jul30 Jul26 Aug18 Sept
Daily closes · updates after each session

No analyst calls on this stock in the last 90 days yet.

Explore by date range →

Analyst opinions

No analyst calls on Nifty MidSmall Healthcare in the last 90 days.

Index metrics

As of 20 Sept, 10:26 IST

Open

52,084.4

Day High

52,674.3

Day Low

52,058.05

Prev. Close

52,017.55

52W High

53,054.05

52W Low

40,352.9

P/E

45.68

P/B

5.51

Div. Yield

0.29%

Member stocks today

How many of this index's member stocks rose or fell today — a broad move and a few-heavyweights move look very different here.

21

Rose

9

Fell

0

Flat

Composition

30 stocks · 21 advanced · 9 declined

Member stocks, ranked by index weight — heaviest first.

Top weight: LAURUSLABS · 11.4% (free-float mcap share, estimate — not NSE’s published weight)

StockWeightPrice · Day

Index levels are informational only, not investment advice.

BIOCON

Biocon stock holds steady as investors digest Q1 FY27 earnings

Biocon stock is trading steadily as investors assess the company's Q1 FY27 earnings. The company reported consolidated revenue of INR 4,336 crore and a net profit of INR 141 crore for the quarter ended June 30, 2026. Investors are scrutinizing these figures for insights into margin improvement and growth drivers.

9 hours ago·Read at AD HOC NEWS
FORTIS

Fortis Healthcare (NSE:FORTIS) Hospital Expansion and Supreme Court Petition Update

Kalkine India · 22 hours ago

ABBOTINDIA

Abbott India stock rallies as investors respond to strong recent earnings

Abbott India stock rallied over 5% on September 18, 2026, reaching an intraday high of INR 27,490. Investors responded to strong recent earnings, with the company reporting high single-digit revenue growth and double-digit net profit expansion in its latest quarter. The stock outperformed its sector peers, supported by positive technical indicators.

PFIZER

Pfizer’s Dividend Yield Is Enormous. But Is the Payout Still Growing?

Pfizer's dividend growth streak ended in January 2026, with the quarterly payout remaining at $0.43 after over a decade of increases. While the 6.20% yield is maintained and management affirmed commitment to the dividend, the pause contrasts with peers like Merck and Bristol-Myers Squibb, who recently raised theirs. This comes as Pfizer faces declining sales for Comirnaty and Paxlovid, alongside generic competition.

LAURUSLABS

Laurus Labs: Q1 FY27 Revenue Jumps 29% to ₹2,026 Crore

InvestyWise · 2 days ago

LUPIN

Lupin Share Price Rises 2.52%: Price, Valuation, Peer View

Lupin Ltd. shares rose 2.52% to Rs 2,144.70, closing at its day's high with a market capitalization of Rs 93,611.47 crore. The stock's P/E ratio of 17.3x is below the industry median, while its ROE and ROCE are above. This movement occurred without a specific company-related catalyst.

2 days ago·Read at univest.in
ALKEM

Alkem Laboratories Share Price rises 3.03% with analysis

Univest · 2 days ago

GLAXO

GLAXO Share Price today after 3.20% rise; valuation view

Univest · 2 days ago

GLAND

Gland Pharma stock gains after bulk deal lifts sentiment

AD HOC NEWS · 2 days ago

FORTIS

Max Healthcare Institute Share Price rises 2%

Univest · 2 days ago

NEULANDLAB

Neuland Laboratories (NSE: NEULANDLAB) Investor Meeting and Peptide Capacity Expansion Update

Kalkine India · 2 days ago

ONESOURCE

OneSource Specialty Pharma stock: what the FY28 bet rests on

Value Research · 2 days ago

MEDANTA

Medanta Adds 47% More Beds, Occupancy Still Rises; Investec Initiates With 'Buy' — Can Margins Catch Up?

NDTV Profit · 2 days ago

GRANULES

Hyderabad Granules promoter sells 7% stake to raise 1.5k crore

The Times of India · 2 days ago

NH

Narayana Hrudayalaya plans to add around 500 beds in Delhi by FY29

Narayana Hrudayalaya Ltd. plans to add approximately 500 beds in Delhi by fiscal year 2029 as part of its expansion strategy in the national capital. This addition is included in the company's projected capital expenditure program through 2029, which totals around INR 30 billion. The expansion aims to address the shortage of hospital beds in Delhi and meet the significant healthcare demand in North India.

2 days ago·Read at Informist
GLAND

Nifty Pharma Today: Up 1.66% to 26,579.25

Univest · 3 days ago

LAURUSLABS

Is Laurus (LAURUSLABS.NS) Still a Buy After +2.24% Rally? 2026-09-17 - VOLD Alert

siam.in · 3 days ago

MEDANTA

Global Health Updates: ByteDance AI Spin-off, Cancer Drug Expansion, and Vaccine Challenges

Devdiscourse · 3 days ago

LUPIN

Lupin Share Price rises 2.04%: valuation, peers, sector

Univest · 3 days ago

PFIZER

Pfizer's Dividend Faces Big Questions. Here Are 3 Reasons It Should Survive.

The Motley Fool · 3 days ago